H1 grew 22%, full-year guide is 20%. Management is signaling back-half deceleration while calling the quarter a structural shift.
Thesis: Operating performance is real: opex up 5% on revenue up 19%, operating margin expansion of 300bps, and eight-figure bookings across secureWISE and DirectScan. But capital efficiency is deteriorating. CapEx consumed 86% of operating cash flow, component costs are rising with no stated pricing offset, and the 77% gross margin target faces admitted cost inflation. The market is pricing a structural shift while the guidance embeds back-half deceleration.
Verdict: HOLD — Conviction: MEDIUM
Catalyst: Q3 gross margin reverting above 73% confirms the perpetual license distortion was temporary and the 77% target remains achievable despite component cost pressure. Backlog exiting the year above $300M with Q2's secureWISE and DirectScan contracts converting to recognized revenue.
Key Risk: Component cost inflation on DirectScan and eProbe (CFO: 'higher component costs'; CEO: computing and memory costs 'keep going up') breaks the 77% gross margin guide while CapEx rises quarter over quarter, compressing free cash flow to near zero.
The Tell: CFO Raza volunteered unprompted that 'our backlog would be even higher if we included some estimates of these highly probable future amounts.' This is an invitation to value revenue that does not exist yet, revealing awareness that the headline $271M number underdelivers against the bullish narrative he is building.
Friction Level: MODERATE_FRICTION — Both sides accept the numbers. Bull reads backlog and booking quality as structural demand (secureWISE standardization, DirectScan aperture widening). Bear reads the same data as cyclical with declining backlog coverage (4.5 to 4.4 quarters), rising hardware costs, and a cash balance built on secondary issuance.
2026Q2 · Aug 6, 2026
3 of 5 readings agreed3 HOLD · 2 LONGRead the full call
Backlog Up 16%, Coverage Down. Guidance Reaffirmed Below First-Half Pace
Operating performance is real: opex up 5% on revenue up 19%, operating margin expansion of 300bps, and eight-figure bookings across secureWISE and DirectScan. But capital efficiency is deteriorating. CapEx consumed 86% of operating cash flow, component costs are rising with no stated pricing offset, and the 77% gross margin target faces admitted cost inflation. The market is pricing a structural shift while the guidance embeds back-half deceleration.
CFO Raza volunteered unprompted that 'our backlog would be even higher if we included some estimates of these highly probable future amounts.' This is an invitation to value revenue that does not exist yet, revealing awareness that the headline $271M number underdelivers against the bullish narrative he is building.
Management guides gross margin to 77% while CFO acknowledges 'higher component costs' driving CapEx up and CEO confirms computing and memory costs 'keep going up' on eProbe. No pricing offset is stated for hardware cost inflation.
Backlog of $271M represents 4.4 quarters of coverage, down from ~4.5 a year ago. Gainshare and Cimetrix runtime revenue are excluded. The eight-figure secureWISE contract is a multi-year minimum, so bookings outpace recognition by construction.
Revenue up 19% YoY, operating margins up 300bps, EPS up 42%, opex growth of only 5%. Bookings across all product lines with record Cimetrix and multiple eight-figure contracts.
secureWISE committed across all 300mm fabs for a major equipment customer with contract value defined as a minimum that grows. Intel standardization makes secureWISE available to any equipment vendor at their fabs, embedding the platform.
CapEx of $14.1M with Q3 and Q4 guided higher, directed at eProbe production and longer lead-time DirectScan components. Management is building inventory ahead of demand, not just talking about it.
-25
CAUTIOUS"Kibarian deflected on 2027 eProbe targets ('hopefully by later this year'), would not commit on eval conversion ('if it will convert'), and conceded cycle position is 'debatable.' Raza volunteered that backlog excludes Gainshare and runtime revenue, inviting hypothetical upside rather than committing to it."
Specific financials throughout: revenue, backlog, margins, CapEx, cash flow all quantified. Backlog quality disclosed voluntarily. Deflections on 2027 capacity and eval conversion. Balance sheet math partially contradictory ($1.9M primary vs $81.8M added).
Q3 gross margin reverting above 73% confirms the perpetual license distortion was temporary and the 77% target remains achievable despite component cost pressure. Backlog exiting the year above $300M with Q2's secureWISE and DirectScan contracts converting to recognized revenue.
Component cost inflation on DirectScan and eProbe (CFO: 'higher component costs'; CEO: computing and memory costs 'keep going up') breaks the 77% gross margin guide while CapEx rises quarter over quarter, compressing free cash flow to near zero.
The verdict is public. The case behind it is Pro: the forensic reading of guidance and language, the bull and bear cases, the red flags, and the play. It opens to everyone on Nov 4, 2026.